98 related articles for article (PubMed ID: 24412588)
1. The co-existence of myasthenia gravis in patients with myositis: a case series.
Paik JJ; Corse AM; Mammen AL
Semin Arthritis Rheum; 2014 Jun; 43(6):792-6. PubMed ID: 24412588
[TBL] [Abstract][Full Text] [Related]
2. Myasthenia gravis with inclusion body myositis: A case report.
Kakutani T; Yoshizawa M
Mod Rheumatol Case Rep; 2023 Dec; 8(1):83-85. PubMed ID: 37210209
[TBL] [Abstract][Full Text] [Related]
3. Anti-Kv1.4 Antibody-positive Nivolumab-induced Myasthenia Gravis and Myositis Presenting with Bilateral Ptosis and Demonstrating Different Pathophysiologies.
Kitazaki Y; Yamamura O; Usui K; Ueno A; Sanada S; Sasaki H; Endo Y; Enomoto S; Ikawa M; Nakamoto Y; Hamano T
Intern Med; 2023; 62(20):3013-3020. PubMed ID: 37839874
[TBL] [Abstract][Full Text] [Related]
4. Clinical features, diagnosis, and management of pembrolizumab-induced myasthenia gravis.
Zhao S; Zhou Y; Sun W; Li Z; Wang C
Clin Exp Immunol; 2023 Mar; 211(2):85-92. PubMed ID: 36426591
[TBL] [Abstract][Full Text] [Related]
5. An Atypical Presentation of Myasthenia Gravis: A Case Report.
Asghar H; Sheikh FN; Dev H; Lazarevic MB; Hassan SA
Cureus; 2019 Apr; 11(4):e4563. PubMed ID: 31281747
[TBL] [Abstract][Full Text] [Related]
6. Polymyositis following varicella and mumps infection in adults: report of two cases.
Masini F; Gjeloshi K; Pinotti E; Ferrara R; Romano C; Cuomo G
Reumatismo; 2023 Dec; 75(4):. PubMed ID: 38115780
[TBL] [Abstract][Full Text] [Related]
7. Management of respiratory failure in immune checkpoint inhibitors-induced overlap syndrome: a case series and review of the literature.
Cuenca JA; Hanmandlu A; Wegner R; Botdorf J; Tummala S; Iliescu CA; Nates JL; Reddy DR
BMC Anesthesiol; 2023 Sep; 23(1):310. PubMed ID: 37700240
[TBL] [Abstract][Full Text] [Related]
8. Rare case of overlap of myositis and myasthenia gravis.
Zeb S; Sagdeo A; Amarasena R
Clin Med (Lond); 2022 Jul; 22(Suppl 4):47. PubMed ID: 36220202
[No Abstract] [Full Text] [Related]
9. [Pediatric myasthenia with ocular involvement].
Prud'homme L; Gitiaux C; Barnerias C; Orssaud C; Bremond-Gignac D; Robert MP
J Fr Ophtalmol; 2024 May; 47(7):104202. PubMed ID: 38723375
[TBL] [Abstract][Full Text] [Related]
10. Correspondence on 'Current myositis clinical trials and tribulations' by Saygin
Azevedo SF; Valenzuela A; Benitez CA; Isenberg DA; Naddaf E; Chinoy H; Vencovský J; Gupta L; McCann L; Kuwana M; Dimachkie MM; Shenoi S; Saketkoo LA; Machado PM
Ann Rheum Dis; 2024 Mar; ():. PubMed ID: 38548314
[No Abstract] [Full Text] [Related]
11. Editorial Comment to Pembrolizumab-induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer.
Tomisaki I
IJU Case Rep; 2020 Jan; 3(1):20. PubMed ID: 32743460
[No Abstract] [Full Text] [Related]
12. Response to: Correspondence on 'Current myositis clinical trials and tribulations' by Saygin
Saygin D; Werth V; Paik JJ; Park JK; Needham M; Lundberg IE; Christopher-Stine L
Ann Rheum Dis; 2024 Mar; ():. PubMed ID: 38548313
[No Abstract] [Full Text] [Related]
13. Atypical antinuclear matrix protein 2-positive dermatomyositis presenting with anasarca and bulbar weakness after COVID-19 infection requiring mechanical ventilation.
Dinneen B; Stack J
Arch Rheumatol; 2024 Jun; 39(2):312-313. PubMed ID: 38933725
[No Abstract] [Full Text] [Related]
14. Dermatomyositis and myastenia gravis: An uncommon association with therapeutic implications.
Sangüesa Gómez C; Flores Robles BJ; Méndez Perles C; Barbadillo C; Godoy H; Andréu JL
Reumatol Clin; 2015; 11(4):244-6. PubMed ID: 25498320
[TBL] [Abstract][Full Text] [Related]
15. Neuromuscular junction disorders mimicking myopathy.
Mongiovi PC; Elsheikh B; Lawson VH; Kissel JT; Arnold WD
Muscle Nerve; 2014 Nov; 50(5):854-6. PubMed ID: 24862941
[TBL] [Abstract][Full Text] [Related]
16. Concurrent inflammatory myopathy and myasthenia gravis with or without thymic pathology: A case series and literature review.
Huang K; Shojania K; Chapman K; Amiri N; Dehghan N; Mezei M
Semin Arthritis Rheum; 2019 Feb; 48(4):745-751. PubMed ID: 29958689
[TBL] [Abstract][Full Text] [Related]
17. Myasthenia gravis with tongue muscle atrophy: A case series.
Zhao XL; Zheng YL; Yang CL; Wang JY; Liu Y; Du T; Zhao ZY; Duan RS; Li XL
Heliyon; 2024 May; 10(9):e30015. PubMed ID: 38707411
[TBL] [Abstract][Full Text] [Related]
18. Random walk with restart on multilayer networks: from node prioritisation to supervised link prediction and beyond.
Baptista A; Brière G; Baudot A
BMC Bioinformatics; 2024 Feb; 25(1):70. PubMed ID: 38355439
[TBL] [Abstract][Full Text] [Related]
19. Clinical features of myasthenia gravis with neurological and systemic autoimmune diseases.
Zhu Y; Wang B; Hao Y; Zhu R
Front Immunol; 2023; 14():1223322. PubMed ID: 37781409
[TBL] [Abstract][Full Text] [Related]
20. Peripheral nervous system adverse events associated with immune checkpoint inhibitors.
Rossi S; Gelsomino F; Rinaldi R; Muccioli L; Comito F; Di Federico A; De Giglio A; Lamberti G; Andrini E; Mollica V; D'Angelo R; Baccari F; Zenesini C; Madia P; Raschi E; Cortelli P; Ardizzoni A; Guarino M
J Neurol; 2023 Jun; 270(6):2975-2986. PubMed ID: 36800019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
